Patents by Inventor Lailing Ku

Lailing Ku has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hepatitis B Virus (HBV) Specific Oligonucleotide Sequences
    Publication number: 20100255482
    Abstract: The present invention relates to oligonucleotide sequences for amplification primers and detection probes and to their use in nucleic acid amplification methods for the detection of HBV in biological samples. In particular, oligonucleotide sequences are provided for the sensitive qualitative or quantitative detection of all eight HBV genotypes. The invention also provides oligonucleotide primer sets and primer/probe sets in the form of kits for the diagnosis of HBV infection.
    Type: Application
    Filed: October 29, 2008
    Publication date: October 7, 2010
    Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.
    Inventors: Lu-ping Shen, Carrie Li Wong, Lailing Ku, Andy Ying, Charlene Bush-Donovan
  • Chlamydia Trachomatis Specific Oligonucleotide Sequences
    Publication number: 20100248220
    Abstract: The present invention relates to oligonucleotide sequences for amplification primers and detection probes and to their use in nucleic acid amplification methods for the selective and specific detection of Chlamydia trachomatis in biological samples. The invention also provides oligonucleotide primer sets and primer/probe sets in the form of kits for the detection and diagnosis of chlamydial infection. The inventive oligonucleotide primers and probes can also be used in combination with other specific oligonucleotide primers and probes for the simultaneous detection of Chlamydia trachomatis and other target organisms, such as Neisseria gonorrhea.
    Type: Application
    Filed: November 7, 2006
    Publication date: September 30, 2010
    Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.
    Inventors: Lailing Ku, Charlene Bush-Donovan, David Sheman, Qi Meng
  • specific oligonucleotide sequences
    Patent number: 7790386
    Abstract: The present invention relates to oligonucleotide sequences for amplification primers and detection probes and their use in nucleic acid amplification methods for the selective and specific detection of Neisseria gonorrhoeae in biological samples. The invention also provides oligonucleotide primer sets and primer/probe sets in the form of kits for the detection and diagnosis of gonococcal infection. The inventive oligonucleotide primers and probes can also be used in combination with other specific oligonucleotide primers and probe for the simultaneous detection of Neisseria gonorrhoeae and other target organisms, such as Chlamydia trachomatis.
    Type: Grant
    Filed: April 6, 2007
    Date of Patent: September 7, 2010
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Lailing Ku, Charlene Bush-Donovan, David Sherman, Qi Meng
  • REAGENTS AND METHODS FOR DETECTING CYP2D6 POLYMORPHISMS
    Publication number: 20100105041
    Abstract: The present invention relates to oligonucleotide sequences for amplification primers and detection probes and their use in nucleic acid amplification methods for the specific detection of clinically relevant CYP2D6 polymorphisms, in particular CYP2D6 polymorphisms associated with adverse drug response. The oligonucleotide sequences are also provided assembled as kits that can be used to predict how an individual will respond to drugs or other xenobiotic compounds that are metabolized, at least in part, by CYP2D6.
    Type: Application
    Filed: December 14, 2007
    Publication date: April 29, 2010
    Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.
    Inventors: Lailing Ku, Charlene Bush-Donovan, Lu-ping Shen
  • Reagents and Methods for Detecting CYP2C9 Polymorphisms
    Publication number: 20100047800
    Abstract: The present invention relates to oligonucleotide sequences for amplification primers and detection probes and their use in nucleic acid amplification methods for the specific detection of clinically relevant CYP2C9 polymorphisms, in particular CYP2C9 polymorphisms associated with adverse drug response. The oligonucleotide sequences are also provided assembled as kits that can be used to predict how an individual will respond to drugs or other xenobiotic compounds that are metabolized, at least in part, by CYP2C9.
    Type: Application
    Filed: January 22, 2008
    Publication date: February 25, 2010
    Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.
    Inventors: Minxue Zheng, Lailing Ku, Lu-ping Shen, Carrie Wong, Charlene Bush-Donovan
  • Neisseria gonorrhoeae specific oligonucleotide sequences
    Publication number: 20080090240
    Abstract: The present invention relates to oligonucleotide sequences for amplification primers and detection probes and their use in nucleic acid amplification methods for the selective and specific detection of Neisseria gonorrhoeae in biological samples. The invention also provides oligonucleotide primer sets and primer/probe sets in the form of kits for the detection and diagnosis of gonococcal infection. The inventive oligonucleotide primers and probes can also be used in combination with other specific oligonucleotide primers and probe for the simultaneous detection of Neisseria gonorrhoeae and other target organisms, such as Chlamydia trachomatis.
    Type: Application
    Filed: April 6, 2007
    Publication date: April 17, 2008
    Inventors: Lailing Ku, Charlene Bush-Donovan, David Sherman, Qi Meng